| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/11/2001 | EP1090642A2 Vaccines comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein |
| 04/11/2001 | EP1090130A1 Protein c derivatives |
| 04/11/2001 | EP1090123A2 Polyketides and their synthesis |
| 04/11/2001 | EP1090034A2 Novel staphylococcus peptides for bacterial interference |
| 04/11/2001 | EP1090033A1 Particles of hcv envelope proteins: use for vaccination |
| 04/11/2001 | EP1090018A1 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY |
| 04/11/2001 | EP1090014A1 Arylsulfonanilide phosphates |
| 04/11/2001 | EP1090012A1 Inhibitors of prenyl-protein transferase |
| 04/11/2001 | EP1090011A1 Inhibitors of prenyl-protein transferase |
| 04/11/2001 | EP1090001A1 (heterocyclic)methyl substituted carbapenem antibacterials |
| 04/11/2001 | EP1090000A1 Naphtho 1,8-de]thiasin-2-yl methyl carbapenem antibacterials |
| 04/11/2001 | EP1089999A1 (heterocyclic) methyl substituted carbapenem antibacterials |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089969A1 Stable no-delivering compounds |
| 04/11/2001 | EP1089759A1 Synthetic peptide vaccines for foot-and-mouth disease |
| 04/11/2001 | EP1089757A1 Hla binding peptides and their uses |
| 04/11/2001 | EP1089756A1 CORRELATIVE PROTECTION USING OspA ANTIBODY TITERS |
| 04/11/2001 | EP1089755A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 04/11/2001 | EP1089753A2 Use of a dipeptide for stimulating repair processes |
| 04/11/2001 | EP1089752A1 Alpha-keto oxadiazoles as serine protease inhibitors |
| 04/11/2001 | EP1089747A1 Compounds obtained from salvia species having antiviral activity |
| 04/11/2001 | EP1089741A1 Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv |
| 04/11/2001 | EP1089730A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/11/2001 | EP1089729A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/11/2001 | EP1089726A2 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid |
| 04/11/2001 | EP1089718A1 Sticking plaster for controlled release of natural interferon |
| 04/11/2001 | EP1089713A1 Temperature-sensitive liposomal formulation |
| 04/11/2001 | EP1021176A4 Cobalt schiff base compounds |
| 04/11/2001 | EP0936866A4 Compounds, compositions and methods for treating antibiotic-resistant infections |
| 04/11/2001 | EP0750506B1 Broad spectrum antimicrobial compounds and methods of use |
| 04/11/2001 | CN1291192A 5,6,7-trino-4,8-inter-m-phenylene PGI2 derivative and drugs containing the same |
| 04/11/2001 | CN1291184A Cycloalkene derivatives, process for producing the same and use |
| 04/11/2001 | CN1291103A Herbal composition for the prophylaxis and treatment of AIDS |
| 04/11/2001 | CN1291098A Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors |
| 04/11/2001 | CN1290707A Nucleoside 5'-thiophosphoryl amino-acid ester compound |
| 04/11/2001 | CN1290534A Quick-acting spray composition for proverting cold and its preparing method |
| 04/11/2001 | CN1290529A Fast-acting antiphlogistic and itch-stopping cream |
| 04/11/2001 | CN1064357C Novel antimicrobial 5-(N-heterosubstiluted amino) quinolones and medicinal composition |
| 04/10/2001 | US6214993 Process for preparing guanine under superatmospheric pressure |
| 04/10/2001 | US6214992 Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation |
| 04/10/2001 | US6214970 Hepatitis E virus antigens and uses therefor |
| 04/10/2001 | US6214883 Benzamidoxime prodrugs as antipneumocystic agents |
| 04/10/2001 | US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia |
| 04/10/2001 | US6214876 Indene-1-acetamide sPLA2 inhibitors |
| 04/10/2001 | US6214866 Composition comprising mupirocin and chlorhexidine |
| 04/10/2001 | US6214861 Enzyme inhibitor; viricides |
| 04/10/2001 | US6214857 Substituted alkanohydroxamic acids and method of reducing TNFα levels |
| 04/10/2001 | US6214844 Substituted imidazole compounds |
| 04/10/2001 | US6214836 Water soluble analogues of 20(S)-camptothecin |
| 04/10/2001 | US6214832 Bis-piperidinyl-pyrimidin-2-ones as alpha 1a adrenergic receptor antagonists |
| 04/10/2001 | US6214811 Viricides and prodrugs |
| 04/10/2001 | US6214805 Genes, gene signals, genomes rna strands and respiratory syncytial virus with promoters |
| 04/10/2001 | US6214801 Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents |
| 04/10/2001 | US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections |
| 04/10/2001 | US6214584 Nucleotide sequence which encodes polypeptide associated with immunocompetence; for use in the treatment and prevent of tumors, viral diseases, bacterial infections and autoimmune diseases |
| 04/10/2001 | US6214543 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 04/10/2001 | US6214540 Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
| 04/10/2001 | US6214367 For treating parasitic diseases and preventing bacterial and viral diseases in warm-blooded animals; stability |
| 04/10/2001 | US6214360 Pharmaceutical composition |
| 04/10/2001 | US6214359 Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant Streptococcus pneumoniae |
| 04/10/2001 | US6214355 DbpA compositions |
| 04/10/2001 | US6214354 Immunizing a person older than fifty who has had varicella or who has had a live varicella vaccine with immunologically effective amount of attenuated varicella zoster virus oka strain, where amount is at least 1,000 plaque forming units |
| 04/10/2001 | US6214350 Contacting comminuted fruit of ligustrum lucidum and/or ligustrum japonicum and mixtures thereof with water to form an aqueous dispersion, separating insoluble material from aqueous solution, acidifying, purifying |
| 04/10/2001 | US6214348 Administering to the mammal a polypeptide comprising seq id no:2 in an amount sufficient to induce an immunological response to produce antibodies to seq id no:2 |
| 04/10/2001 | US6214347 Multideterminant peptides that elicit helper T-lymphocyte, cytotoxic T lymphocyte and neutralizing antibody responses against HIV-1 |
| 04/10/2001 | US6214346 Bactericides |
| 04/10/2001 | US6214341 Percutaneously administering to patient an effective amount of human clostridium difficile toxin-neutralizing polyclonal immune globulin obtained from a human subject immunized with a clostridium difficile toxin or toxoid |
| 04/10/2001 | US6214335 Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria |
| 04/10/2001 | US6214318 Comprising mineral oils, vegetable oils, silicone oils or synthetic oils; thickening agents such as waxes to thicken oils to non-flowable state; optionally adjuvants, drugs and emulsifiers and a liquefied propellant; cooling effect |
| 04/10/2001 | CA2200855C Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/10/2001 | CA2191858C Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 04/10/2001 | CA2190344C Quillaja saponin adjuvant and vaccine formulation containing same |
| 04/10/2001 | CA2059263C Composition comprising the (-) enantiomer of cis-4-amino-1-(2-hydromethyl-1,3-oxathiolan-5-yl)-(1h)-pyrimidine-2-one or an enriched composition thereof, and its uses as a pharmaceutical agent |
| 04/10/2001 | CA2019410C Liquid polymer composition, and method of use |
| 04/05/2001 | WO2001023604A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023597A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023572A2 Polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |
| 04/05/2001 | WO2001023547A1 26 human secreted proteins |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023540A2 P-glycoproteins and uses thereof |
| 04/05/2001 | WO2001023422A1 Vaccine |
| 04/05/2001 | WO2001023421A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | WO2001023416A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 04/05/2001 | WO2001023414A2 Immunologically significant herpes simplex virus antigens |
| 04/05/2001 | WO2001023413A1 Extracorporeal endotoxin removal method |
| 04/05/2001 | WO2001023409A2 38 human secreted proteins |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001023386A2 Benzodiazepin derivatives, the production and use thereof |
| 04/05/2001 | WO2001023379A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/05/2001 | WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/05/2001 | WO2001023372A1 Anti-drug resistant strain agents and antichlamydia agents |
| 04/05/2001 | WO2001023362A2 Rate-controlled particles |
| 04/05/2001 | WO2001023360A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/05/2001 | WO2001023357A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/05/2001 | WO2001023342A1 Phloroglucinol compounds |
| 04/05/2001 | WO2001023006A1 Low dose ifn-gamma for treatment of disease |
| 04/05/2001 | WO2001022994A2 Vaccines against neisseria infection |